Mark Christopher Capone is Director of DermTech, Inc.. Currently has a direct ownership of 82,054 shares of DMTK, which is worth approximately $3,282. The most recent transaction as insider was on Jun 01, 2023, when has been sold 35,714 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 82.1K
0% 3M change
0% 12M change
Total Value Held $3,282

Mark Christopher Capone Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 01 2023
BUY
Grant, award, or other acquisition
-
35,714 Added 30.33%
82,054 Common Stock
Jul 18 2022
BUY
Grant, award, or other acquisition
-
46,340 Added 50.0%
46,340 Common Stock

Also insider at

MLAB
MESA LABORATORIES INC Technology
MCC

Mark Christopher Capone

Director
La Jolla, CA

Track Institutional and Insider Activities on DMTK

Follow DermTech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DMTK shares.

Notify only if

Insider Trading

Get notified when an Derm Tech, Inc. insider buys or sells DMTK shares.

Notify only if

News

Receive news related to DermTech, Inc.

Track Activities on DMTK